> top > docs > PubMed:12784657 > annotations

PubMed:12784657 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-159 Sentence denotes [Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome].
TextSentencer_T2 160-382 Sentence denotes We report a late appearance of the Philadelphia chromosome (Ph) with the p190 BCR/ABL chimeric transcript in a 69-year-old patient with acute myelogenous leukemia (AML) that had evolved from myelodysplastic syndrome (MDS).
TextSentencer_T3 383-526 Sentence denotes In July 1997, the patient was found to have pancytopenia caused by refractory anemia with excess of blasts, which evolved into AML in 4 months.
TextSentencer_T4 527-620 Sentence denotes The leukemic cells were positive for CD13, CD14, CD33, and HLA-DR and had a normal karyotype.
TextSentencer_T5 621-694 Sentence denotes The patient achieved a complete remission after combination chemotherapy.
TextSentencer_T6 695-863 Sentence denotes However, his leukemia relapsed in November 1999, with the appearance of leukemic cells positive for CD7, CD13, CD34, and HLA-DR with a 46, XY, add (18) (p11) karyotype.
TextSentencer_T7 864-963 Sentence denotes The patient failed to achieve the second remission after several courses of intensive chemotherapy.
TextSentencer_T8 964-1196 Sentence denotes When the number of blastic cells, showing the same surface phenotypes, in the peripheral blood increased drastically in April 2000, chromosomal analysis of leukemic cells revealed a 46, XY, t(9;22) (q34;q11), add(18)(p11) karyotype.
TextSentencer_T9 1197-1430 Sentence denotes The fusion of the BCR and ABL genes was confirmed by fluorescence in situ hybridization analysis, and the reverse transcription-polymerase chain reaction analysis further revealed the presence of the p190 BCR/ABL chimeric transcript.
TextSentencer_T10 1431-1570 Sentence denotes The appearance of the Ph chromosome in the course of MDS transforming to AML is very rare and may be correlated to the disease progression.
T1 0-159 Sentence denotes [Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome].
T2 160-382 Sentence denotes We report a late appearance of the Philadelphia chromosome (Ph) with the p190 BCR/ABL chimeric transcript in a 69-year-old patient with acute myelogenous leukemia (AML) that had evolved from myelodysplastic syndrome (MDS).
T3 383-526 Sentence denotes In July 1997, the patient was found to have pancytopenia caused by refractory anemia with excess of blasts, which evolved into AML in 4 months.
T4 527-620 Sentence denotes The leukemic cells were positive for CD13, CD14, CD33, and HLA-DR and had a normal karyotype.
T5 621-694 Sentence denotes The patient achieved a complete remission after combination chemotherapy.
T6 695-863 Sentence denotes However, his leukemia relapsed in November 1999, with the appearance of leukemic cells positive for CD7, CD13, CD34, and HLA-DR with a 46, XY, add (18) (p11) karyotype.
T7 864-963 Sentence denotes The patient failed to achieve the second remission after several courses of intensive chemotherapy.
T8 964-1196 Sentence denotes When the number of blastic cells, showing the same surface phenotypes, in the peripheral blood increased drastically in April 2000, chromosomal analysis of leukemic cells revealed a 46, XY, t(9;22) (q34;q11), add(18)(p11) karyotype.
T9 1197-1430 Sentence denotes The fusion of the BCR and ABL genes was confirmed by fluorescence in situ hybridization analysis, and the reverse transcription-polymerase chain reaction analysis further revealed the presence of the p190 BCR/ABL chimeric transcript.
T10 1431-1570 Sentence denotes The appearance of the Ph chromosome in the course of MDS transforming to AML is very rare and may be correlated to the disease progression.

PubCasesHPO

Id Subject Object Predicate Lexical cue
TI1 107-115 HP:0001909 denotes leukemia
AB1 314-322 HP:0001909 denotes leukemia
AB2 427-439 HP:0001876 denotes pancytopenia
AB3 450-467 HP:0005505 denotes refractory anemia
AB4 708-716 HP:0001909 denotes leukemia

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 1053-1058 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood

PubCasesORDO

Id Subject Object Predicate Lexical cue
AB1 450-467 ORDO:98826 denotes refractory anemia

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 1053-1058 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood

DisGeNET

Id Subject Object Predicate Lexical cue
T0 58-65 gene:25 denotes BCR/ABL
T1 133-157 disease:C3463824 denotes myelodysplastic syndrome
T2 58-65 gene:25 denotes BCR/ABL
T3 133-157 disease:C0033027 denotes myelodysplastic syndrome
T4 58-65 gene:25 denotes BCR/ABL
T5 133-157 disease:C0026986 denotes myelodysplastic syndrome
T6 58-65 gene:25 denotes BCR/ABL
T7 89-115 disease:C0023467 denotes acute myelogenous leukemia
T8 53-57 gene:8506 denotes p190
T9 133-157 disease:C3463824 denotes myelodysplastic syndrome
T10 53-57 gene:8506 denotes p190
T11 133-157 disease:C0033027 denotes myelodysplastic syndrome
T12 53-57 gene:8506 denotes p190
T13 89-115 disease:C0023467 denotes acute myelogenous leukemia
T14 53-57 gene:8506 denotes p190
T15 133-157 disease:C0026986 denotes myelodysplastic syndrome
T16 238-245 gene:25 denotes BCR/ABL
T17 377-380 disease:C0026986 denotes MDS
T18 238-245 gene:25 denotes BCR/ABL
T19 351-375 disease:C0026986 denotes myelodysplastic syndrome
T20 238-245 gene:25 denotes BCR/ABL
T21 296-327 disease:C0023467 denotes acute myelogenous leukemia (AML
T22 233-237 gene:8506 denotes p190
T23 377-380 disease:C0026986 denotes MDS
T24 233-237 gene:8506 denotes p190
T25 351-375 disease:C0026986 denotes myelodysplastic syndrome
T26 233-237 gene:8506 denotes p190
T27 296-327 disease:C0023467 denotes acute myelogenous leukemia (AML
R1 T0 T1 associated_with BCR/ABL,myelodysplastic syndrome
R2 T2 T3 associated_with BCR/ABL,myelodysplastic syndrome
R3 T4 T5 associated_with BCR/ABL,myelodysplastic syndrome
R4 T6 T7 associated_with BCR/ABL,acute myelogenous leukemia
R5 T8 T9 associated_with p190,myelodysplastic syndrome
R6 T10 T11 associated_with p190,myelodysplastic syndrome
R7 T12 T13 associated_with p190,acute myelogenous leukemia
R8 T14 T15 associated_with p190,myelodysplastic syndrome
R9 T16 T17 associated_with BCR/ABL,MDS
R10 T18 T19 associated_with BCR/ABL,myelodysplastic syndrome
R11 T20 T21 associated_with BCR/ABL,acute myelogenous leukemia (AML
R12 T22 T23 associated_with p190,MDS
R13 T24 T25 associated_with p190,myelodysplastic syndrome
R14 T26 T27 associated_with p190,acute myelogenous leukemia (AML